Müller-Richter U - Search Results

1

Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies.

Lorini L, Bescós Atín C, Thavaraj S, Müller-Richter U, Alberola Ferranti M, Pamias Romero J, Sáez Barba M, de Pablo García-Cuenca A, Braña García I, Bossi P, Nuciforo P, Simonetti S. Lorini L, et al. Cancers (Basel). 2021 Jul 23;13(15):3696. doi: 10.3390/cancers13153696. Cancers (Basel). 2021. PMID: 34359597 Free PMC article. Review.

2

Impact of MAGE-A antigens on taxane response in oral squamous cell carcinoma.

Müller-Richter UD, Dowejko A, Driemel O, Reuther T, Reichert TE, Kübler AC. Müller-Richter UD, et al. Oncol Lett. 2010 Jan;1(1):181-185. doi: 10.3892/ol_00000033. Epub 2010 Jan 1. Oncol Lett. 2010. PMID: 22966279 Free PMC article.

3

The prognostic value of GLUT-1 staining in the detection of malignant transformation in oral mucosa.

Brands RC, Köhler O, Rauthe S, Hartmann S, Ebhardt H, Seher A, Linz C, Kübler AC, Müller-Richter UDA. Brands RC, et al. Clin Oral Investig. 2017 Jun;21(5):1631-1637. doi: 10.1007/s00784-016-1954-5. Epub 2016 Sep 8. Clin Oral Investig. 2017. PMID: 27631596

4

MAGE-A antigens in lesions of the oral mucosa.

Krauss E, Rauthe S, Gattenlöhner S, Reuther T, Kochel M, Kriegebaum U, Kübler AC, Müller-Richter UD. Krauss E, et al. Clin Oral Investig. 2011 Jun;15(3):315-20. doi: 10.1007/s00784-010-0387-9. Epub 2010 Feb 20. Clin Oral Investig. 2011. PMID: 20174843

5

Value of FDG PET/CT in staging of oral cancer: four simultaneous primary malignancies.

Linz C, Müller-Richter UD, Kircher S, Lapa C, Bluemel C. Linz C, et al. Clin Nucl Med. 2015 May;40(5):455-7. doi: 10.1097/RLU.0000000000000734. Clin Nucl Med. 2015. PMID: 25742223

6

Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatin.

Brands RC, Müller-Richter UD, De Donno F, Seher A, Mutzbauer G, Linz C, Kübler AC, Hartmann S. Brands RC, et al. Mol Med Rep. 2016 Mar;13(3):2338-44. doi: 10.3892/mmr.2016.4786. Epub 2016 Jan 14. Mol Med Rep. 2016. PMID: 26782932

7

MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation.

Meyer TJ, Hartmann S, Wohlleben G, Brisam M, Seher A, Kübler AC, Polat B, Müller-Richter UDA. Meyer TJ, et al. Mol Clin Oncol. 2018 Mar;8(3):513-519. doi: 10.3892/mco.2018.1558. Epub 2018 Jan 19. Mol Clin Oncol. 2018. PMID: 29556384 Free PMC article.

8

PKM2 Modulation in Head and Neck Squamous Cell Carcinoma.

Boschert V, Teusch J, Müller-Richter UDA, Brands RC, Hartmann S. Boschert V, et al. Among authors: muller richter uda. Int J Mol Sci. 2022 Jan 11;23(2):775. doi: 10.3390/ijms23020775. Int J Mol Sci. 2022. PMID: 35054968 Free PMC article.

9

Contrary melanoma-associated antigen-A expression at the tumor front and center: A comparative analysis of stage I and IV head and neck squamous cell carcinoma.

Hartmann S, Brisam M, Rauthe S, Driemel O, Brands RC, Rosenwald A, Kübler AC, Müller-Richter UD. Hartmann S, et al. Oncol Lett. 2016 Oct;12(4):2942-2947. doi: 10.3892/ol.2016.4945. Epub 2016 Aug 3. Oncol Lett. 2016. PMID: 27703530 Free PMC article.

10

MAGE-A expression clusters and antineoplastic treatment in head and neck cancer.

Hartmann S, Meyer TJ, Brands RC, Haubitz IR, Linz C, Seher A, Kübler AC, Müller-Richter UD. Hartmann S, et al. Int J Mol Med. 2015 Jun;35(6):1675-82. doi: 10.3892/ijmm.2015.2174. Epub 2015 Apr 7. Int J Mol Med. 2015. PMID: 25872923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters